PEAR BIO
Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
PEAR BIO
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pearbio.com
Total Employee:
11+
Status:
Active
Total Funding:
5.79 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
VectivBio
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Current Employees Featured
Duleek Ranatunga CEO @ Pear Bio
CEO
2019-01-01
Founder
Investors List
Greater London Authority
Greater London Authority investment in Grant - Pear Bio
SOSV
SOSV investment in Seed Round - Pear Bio
Fly Ventures
Fly Ventures investment in Seed Round - Pear Bio
SOSV
SOSV investment in Convertible Note - Pear Bio
RebelBio
RebelBio investment in Convertible Note - Pear Bio
Official Site Inspections
http://www.pearbio.com Semrush global rank: 7 M Semrush visits lastest month: 647
Unable to get host informations!!!
More informations about "Pear Bio"
Pear Bio - Crunchbase Company Profile & Funding
Organization. Pear Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Pear Bio uses …See details»
Pear Bio - LinkedIn
Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient-centric functional precision medicine and ...See details»
Pear Bio Company Profile 2024: Valuation, Funding & Investors
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20230008421-A1: Method of forming solid cell cultures: Pending: 08-Jul-2021See details»
Pear Bio Company Profile | Management and Employees List
Www.pearbio.com Pear Bio Profile and History Pear Bio is a computational biology company that uses organ-on-a-chip and computer vision technology to recreate, visualize and compute the …See details»
Pear Bio - LinkedIn
Pear Bio | 5,856 followers on LinkedIn. Patient-centered cancer precision medicine | Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to …See details»
Pear Bio - Company Profile - Tracxn
Nov 1, 2024 Website: pearbio.com; Social: Key Metrics. Total Funding. $14.2M in 2 rounds. Latest Funding Round. Series A, Apr 14, 2023, $14.2M. Investors. Octopus Ventures & 8 …See details»
Pear Bio - Overview, News & Similar companies | ZoomInfo.com
Who is Pear Bio. Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient …See details»
PEAR BIO Company Profile | LONDON, United Kingdom
Find company research, competitor information, contact details & financial data for PEAR BIO of LONDON. Get the latest business insights from Dun & Bradstreet.See details»
Pear Bio Company Information - Funding, Investors, and More
Insights. Pear Bio, based in London, is disrupting healthcare with its cancer treatment predictor software. Operating on a B2B model, Pear Bio aims to enhance oncologists' decision-making …See details»
Pear Bio Company Profile: , Investments, Contact Information, …
Pear Bio is a computational biology company that uses organ-on-a-chip and computer vision technology to recreate, visualize and compute the human tumor microenvironment and its …See details»
Pear Bio - VentureRadar
We help doctors and pharma companies evaluate cancer drug efficacy using organ-on-a-chip. At Pear Bio, we culture patient-derived tumor cells in a... ... Find out ...See details»
Meet Pear Bio: Revolutionising the way cancer treatments are …
Pear Bio is revolutionising the way cancer treatments are assigned to patients. They have developed a functional precision medicine platform by integrating tissue engineering, confocal …See details»
Pear Bio | Scientist.com
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the …See details»
This startup can predict the success of complex cancer treatments
May 14, 2023 Pear Bio, a techbio startup working on improving the efficacy of cancer drug treatments, has raised a $14m Series A round led by Octopus Ventures, with participation …See details»
Pear Bio - ASCO Annual 2024
Jun 3, 2024 Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient-centric functional ... - …See details»
Cytiva and Pear Bio empower personalized cancer medicine with ...
Sep 25, 2024 Discover how Cytiva and Pear Bio are using advanced 3D tumor models and single-cell technology to improve personalized cancer treatments and drug efficacy testing.See details»
The Healthtech VC: Duleek Ranatunga, Founder of Pear Bio.
Jun 14, 2022 Listen to the full episode of The Healthtech VC podcast on Spotify or Apple Podcasts.. Oncological (cancer) treatment regimens are often multiple drugs, used in various …See details»
Pear Bio and the Ever-expanding World of Tailored Oncology
Aug 25, 2020 Written by Oscar Drury, 25th August 2020 In a world reliant upon standard patient care within oncology, Pear Bio looks to reform how pharmaceutical companies trial new drugs …See details»
Cytiva and Pear Bio Empower Personalized Cancer Medicine with ...
Sep 25, 2024 Setting new benchmarks in cancer treatment research, Cytiva’s Via Extractor tissue disaggregator is being used to create dissociated tumor cell suspensions with high …See details»
Cytiva and Pear Bio empower personalized cancer medicine with ...
Sep 24, 2024 250 First Avenue, Suite 300 Needham, MA 02494 P: 781.972.5400 F: 781.972.5425 E: chi@healthtech.comSee details»